3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Lung Neoplasms
6
Oropharyngeal Neoplasms
5
Mesothelioma, Malignant
5
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Carcinoma
3
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Medulloblastoma
2
Lymphoid Interstitial Pneumonia
2
Hypopharyngeal Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Penile Neoplasms
1
Interventions
Temozolomide
19
Magnetic Resonance Spectroscopy
8
Radiation
7
Specimen Handling
6
Radiotherapy
6
Lomustine
4
Bevacizumab
4
Biopsy
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
cemiplimab
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Photons
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
varlilumab
1
ulixertinib
1
tinostamustine
1
selinexor
1
ruxolitinib
1
ribociclib
1
relatlimab
1
regorafenib
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Platinum
×
30 days
×
Clear all
No trials found.